|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global Cancer Statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deenen MJ, Meulendijks D, Cats A,
Sechterberger MK, Severens JL, Boot H, Smits PH, Rosing H,
Mandigers CM, Soesan M, et al: Upfront genotyping of DPYD*2A to
individualize fluoropyrimidine therapy: A safety and cost analysis.
J Clin Oncol. 34:227–234. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamano T, Yoshimura M, Kobayashi M, Beppu
N, Hamanaka M, Babaya A, Tsukamoto K, Noda M, Matsubara N and
Tomita N: Malnutrition in rectal cancer patients receiving
preoperative chemoradiotherapy is common and associated with
treatment tolerability and anastomotic leakage. Int J Colorectal
Dis. 31:877–884. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ramjiawan RR, Griffioen AW and Duda DG:
Anti-angiogenesis for cancer revisited: Is there a role for
combinations with immunotherapy? Angiogenesis. 20:185–204. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Viallard C and Larrivée B: Tumor
angiogenesis and vascular normalization: Alternative therapeutic
targets. Angiogenesis. 20:409–426. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu H, Li X, Yuan M, Wan W, Hu M, Wang X
and Jiang X: Intramyocardial delivery of bFGF with a biodegradable
and thermosensitive hydrogel improves angiogenesis and
cardio-protection in infarcted myocardium. Exp Ther Med.
14:3609–3615. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zeng M, Shen J, Liu Y, Lu LY, Ding K,
Fortmann SD, Khan M, Wang J, Hackett SF, Semenza GL and Campochiaro
PA: The HIF-1 antagonist acriflavine: Visualization in retina and
suppression of ocular neovascularization. J Mol Med (Berl).
95:417–429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oh ET, Kim CW, Kim HG, Lee JS and Park HJ:
Brusatol-mediated inhibition of c-Myc increases HIF-1α degradation
and causes cell death in colorectal cancer under hypoxia.
Theranostics. 7:3415–3431. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kasai M, Van Damme N, Berardi G, Geboes K,
Laurent S and Troisi RI: The inflammatory response to stress and
angiogenesis in liver resection for colorectal liver metastases: A
randomized controlled trial comparing open versus laparoscopic
approach. Acta Chir Belg. 118:172–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sui H, Zhao J, Zhou L, Wen H, Deng W, Li
C, Ji Q, Liu X, Feng Y, Chai N, et al: Tanshinone IIA inhibits
β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in
normoxic and HIF-1α in hypoxic microenvironments in human
colorectal cancer. Cancer Lett. 403:86–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou LH, Hu Q, Sui H, Ci SJ, Wang Y, Liu
X, Liu NN, Yin PH, Qin JM and Li Q: Tanshinone II-a inhibits
angiogenesis through down regulation of COX-2 in human colorectal
cancer. Asian Pac J Cancer Prev. 13:4453–4458. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salavati H, Soltani M and Amanpour S: The
pivotal role of angiogenesis in a multi-scale modeling of tumor
growth exhibiting the avascular and vascular phases. Microvasc Res.
119:105–116. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang WC, Chen SH, Chiang WH, Huang CW, Lo
CL, Chern CS and Chiu HC: Tumor microenvironment-responsive
nanoparticle delivery of chemotherapy for enhanced selective
cellular uptake and transportation within tumor. Biomacromolecules.
17:3883–3892. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lequeux A, Noman MZ, Xiao M, Sauvage D,
Van Moer K, Viry E, Bocci I, Hasmim M, Bosseler M, Berchem G and
Janji B: Impact of hypoxic tumor microenvironment and tumor cell
plasticity on the expression of immune checkpoints. Cancer Lett.
458:13–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belluco C, Forlin M, Delrio P, Rega D,
Degiuli M, Sofia S, Olivieri M, Pucciarelli S, Zuin M, De Manzoni
G, et al: Elevated platelet count is a negative predictive and
prognostic marker in locally advanced rectal cancer undergoing
neoadjuvant chemoradiation: A retrospective multi-institutional
study on 965 patients. BMC Cancer. 18:10942018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pastorekova S and Gillies RJ: The role of
carbonic anhydrase IX in cancer development: Links to hypoxia,
acidosis, and beyond. Cancer Metastasis Rev. 38:65–77. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Broggini T, Wüstner M, Harms C, Stange L,
Blaes J, Thomé C, Harms U, Mueller S, Weiler M, Wick W, et al:
NDRG1 overexpressing gliomas are characterized by reduced tumor
vascularization and resistance to antiangiogenic treatment. Cancer
Lett. 380:568–576. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu CC, Chen C, Xu ZQ, Zhao JK, Ou BC, Sun
J, Zheng MH, Zong YP and Lu AG: CCR6 promotes tumor angiogenesis
via the AKT/NF-κB/VEGF pathway in colorectal cancer. Biochim
Biophys Acta Mol Basis Dis. 1864:387–397. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barravecchia I, Mariotti S, Pucci A,
Scebba F, De Cesari C, Bicciato S, Tagliafico E, Tenedini E,
Vindigni C, Cecchini M, et al: MICAL2 is expressed in cancer
associated neo-angiogenic capillary endothelia and it is required
for endothelial cell viability, motility and VEGF response. Biochim
Biophys Acta Mol Basis Dis. 1865:2111–2124. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu J, Liu M, Yu M, Shen J, Zhou J, Hu J,
Zhou Y and Zhang W: RasGRP1 is a target for VEGF to induce
angiogenesis and involved in the endothelial-protective effects of
metformin under high glucose in HUVECs. IUBMB Life. 71:1391–1400.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang HJ and Lo WY: Identification of basic
fibroblast growth factor as the dominant protector of laminar shear
medium from the modified shear device in tumor necrosis factor-α
induced endothelial dysfunction. Front Physiol. 8:10952017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han JH, Hwang AR, Nam DH, Kim S, Choi HC,
Lim JH and Woo CH: ERK5 regulates basic fibroblast growth
factor-induced type 1 plasminogen activator inhibitor expression
and cell proliferation in lung fibroblasts. Life Sci. 135:1–8.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng L, Cheng Y, Tong X, Gan S, Ding Y,
Zhang Y, Wang C, Xu L, Zhu Y, Wu J, et al: Tumor oxygenation and
hypoxia inducible factor-1 functional inhibition via a reactive
oxygen species responsive nanoplatform for enhancing radiation
therapy and abscopal effects. ACS Nano. 12:8308–8322. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng Y, Huang G, Chen F, Testroet ED, Li
H, Li H, Nong T, Yang X, Cui J, Shi D and Yang S: Hypoxia enhances
buffalo adipose-derived mesenchymal stem cells proliferation,
stemness, and reprogramming into induced pluripotent stem cells. J
Cell Physiol. 234:17254–17268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han J, Jackson D, Holm J, Turner K,
Ashcraft P, Wang X, Cook B, Arning E, Genta RM, Venuprasad K, et
al: Elevated d-2-hydroxyglutarate during colitis drives progression
to colorectal cancer. Proc Natl Acad Sci USA. 115:1057–1062. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ni T, He Z, Dai Y, Yao J, Guo Q and Wei L:
Oroxylin A suppresses the development and growth of colorectal
cancer through reprogram of HIF1α-modulated fatty acid metabolism.
Cell Death Dis. 8:e28652017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bharti R, Dey G, Das AK and Mandal M:
Differential expression of IL-6/IL-6R and MAO-A regulates
invasion/angiogenesis in breast cancer. Br J Cancer. 118:1442–1452.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Xu S, Zu T, Li F, Sang S, Liu C, An
Y, Mi B, Orgill DP, Murphy GF and Lian CG: Reversal of TET-mediated
5-hmC loss in hypoxic fibroblasts by ascorbic acid. Lab Invest.
99:1193–1202. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maliha AM, Kuehn S, Hurst J, Herms F, Fehr
M, Bartz-Schmidt KU, Dick HB, Joachim SC and Schnichels S:
Diminished apoptosis in hypoxic porcine retina explant cultures
through hypothermia. Sci Rep. 9:48982019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kobayashi M, Morinibu A, Koyasu S, Goto Y,
Hiraoka M and Harada H: A circadian clock gene, PER2, activates
HIF-1 as an effector molecule for recruitment of HIF-1α to promoter
regions of its downstream genes. FEBS J. 284:3804–3816. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fu X, Zhai S and Yuan J: Interleukin-6
(IL-6) triggers the malignancy of hemangioma cells via activation
of HIF-1α/VEGFA signals. Eur J Pharmacol. 841:82–89. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang M, Qiu L, Zhang Y, Xu D, Zheng JC
and Jiang L: CXCL12 enhances angiogenesis through CXCR7 activation
in human umbilical vein endothelial cells. Sci Rep. 7:82892017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Batlle R, Andrés E, Gonzalez L, Llonch E,
Igea A, Gutierrez-Prat N, Berenguer-Llergo A and Nebreda AR:
Regulation of tumor angiogenesis and mesenchymal-endothelial
transition by p38α through TGF-β and JNK signaling. Nat Commun.
10:30712019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren X, Wang C, Xie B, Hu L, Chai H, Ding
L, Tang L, Xia Y and Dou X: Tanshinone IIA induced cell death via
miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular
carcinoma cells. Eur J Pharmacol. 796:233–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Z, Chen L, Xiao Z, Zhu Y, Jiang H, Jin
Y, Gu C, Wu Y, Wang L, Zhang W, et al: Potentiation of the
anticancer effect of doxorubicinin drug-resistant gastric cancer
cells by tanshinone IIA. Phytomedicine. 51:58–67. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qian J, Fang D, Lu H, Cao Y, Zhang J, Ding
R, Li L and Huo J: Tanshinone IIA promotes IL2-mediated SW480
colorectal cancer cell apoptosis by triggering INF2-related
mitochondrial fission and activating the Mst1-Hippo pathway. Biomed
Pharmacother. 108:1658–1669. 2018. View Article : Google Scholar : PubMed/NCBI
|
